AIM
MYOK

Aigen Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Aigen Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,171
Closed -$758K – 1447
2020
Q1 		$758K Buy
16,171
+14,819
+1,096% +$950K 0.1% 293
2019
Q4 		$99K Buy
+1,352
New +$82K 0.02% 685

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Aigen Investment Management's MYOK Position: Q2 2020 in Review

Aigen Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 16,171 shares — an estimated $758K sold.

Aigen Investment Management first reported a position in MYOK in Q4 2019 and held it in 2 quarters. The position peaked at $758K in Q1 2020. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

  • Aigen Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Aigen Investment Management sold 16,171 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $758K.
  • Aigen Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Aigen Investment Management's MyoKardia, Inc. Common Stock position peaked at $758K in Q1 2020.
  • 235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.